Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00261976 · ClinicalTrials.gov registry record

A Long-term Safety Study of Infliximab (Remicade)

A clinical trial, sponsored by Centocor.

Completed
Registry status
2,971
Enrollment target

NCT00261976 is a clinical trial that has completed, run by Centocor. The registered enrollment target is 2,971 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00261976 has completed, sponsored by Centocor.

COMPLETED
Registry status
2,971 participants
Enrollment target

Study Summary

This is a study evaluating the long-term safety of infliximab (Remicade)

Interventions

  • DRUG Infliximab (Remicade)

Trial Details

FieldValue
Enrollment Target 2,971 participants
Start Date 2002-02
Est. Completion 2012-03

Sponsor

Centocor

33 total trials

What the Registry Record Tells You About NCT00261976

The ClinicalTrials.gov registry entry for NCT00261976 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,971 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centocor, which has 33 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Infliximab (Remicade) is the first listed.

NCT00261976 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00261976 about?

NCT00261976 is a clinical study titled "A Long-term Safety Study of Infliximab (Remicade)". This is a study evaluating the long-term safety of infliximab (Remicade)

What is the current status of trial NCT00261976?

This trial is currently completed. The enrollment target is 2,971 participants. The study started on 2002-02. Estimated completion is 2012-03.

What interventions are being tested in trial NCT00261976?

The interventions under investigation include: Infliximab (Remicade) (DRUG).

Who is sponsoring clinical trial NCT00261976?

This trial is sponsored by Centocor, which has 33 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.